To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 5 January 2022 to Question 94362, how much has the Government invested in the Vaccine Manufacture and Innovation Centre since its inception (a) directly and (b) through its agencies; and what other forms of control does the Government exercise of that Centre.
This answer is the replacement for a previous holding answer.
11 January 2022
The Vaccine Manufacturing Innovation Centre (VMIC) UK is a private company, limited by guarantee, and as such the UK Government does not exercise any ownership rights.
VMIC has been granted £206m of Government funding to date to support the delivery of the facility, including grants since the beginning of the COVID-19 pandemic to increase vaccine manufacturing capacity. Reflecting the public funding VMIC has received, UK Research and Innovation (who have been managing the grant on behalf of the Vaccine Taskforce) will be required to ‘consent’ to any sale of the company or its assets and have confirmed that they will work closely with the Vaccine Taskforce in performing this function.